OncoTherapy Science, Inc.

4564.T · JPX
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income-¥1-¥1-¥1-¥3
Dep. & Amort.¥0¥0¥0¥0
Deferred Tax¥0¥0¥0¥1
Stock-Based Comp.¥0¥0¥0¥0
Change in WC-¥0-¥0¥0-¥0
Other Non-Cash¥0¥0-¥0-¥0
Operating Cash Flow-¥1-¥1-¥1-¥2
Investing Activities
PP&E Inv.-¥0-¥0-¥0-¥0
Net Acquisitions¥0¥0¥0¥0
Inv. Purchases¥0¥0¥0¥0
Inv. Sales/Matur.¥0¥0¥0¥0
Other Inv. Act.¥0-¥0-¥0-¥0
Investing Cash Flow-¥0-¥0-¥0-¥0
Financing Activities
Debt Repay.-¥0-¥0¥0¥0
Stock Issued¥1¥1¥0¥1
Stock Repurch.-¥0¥0¥0¥0
Dividends Paid¥0¥0¥0¥0
Other Fin. Act.¥0-¥0¥0¥0
Financing Cash Flow¥1¥1¥0¥1
Forex Effect¥0¥0-¥0-¥0
Net Chg. in Cash¥0-¥1-¥1-¥1
Supplemental Information
Beg. Cash¥1¥1¥2¥3
End Cash¥1¥1¥1¥2
Free Cash Flow-¥1-¥1-¥1-¥3
OncoTherapy Science, Inc. (4564.T) Financial Statements & Key Stats | AlphaPilot